Table 4.
Multivariable Cox proportional hazards model for overall survival.
Variable | HR | P Value |
---|---|---|
Treatment group | ||
TACE+RFA-S vs TACE-S (reference) | 0.67 (0.33, 1.34) | 0.256 |
Type of PVTT | ||
Type II vs Type I (reference) | 2.43 (0.57, 10.27) | 0.228 |
Level of AFP (ng/ml) | ||
≥400 vs <400 (reference) | 1.82 (0.90, 3.68) | 0.096 |
Tumor encapsulation | ||
Yes vs no (reference) | 0.39 (0.16, 0.99) | 0.047 |
Objective response | ||
Yes vs no (reference) | 0.23 (0.11, 0.45) | <0.001 |
Numbers in parentheses are the 95% confidence interval. An objective response is defined as achieving a complete or partial response based on the modified Response Evaluation Criteria for Solid Tumors.
RFA, radiofrequency ablation; TACE, transarterial chemoembolization; S, sorafenib; HR, hazard ratio; CI, confidence interval; AFP, α-fetoprotein.